Your browser doesn't support javascript.
loading
Attenuated Dose Dasatinib in Newly Diagnosed Chronic Myeloid Leukemia Chronic Phase Patients in India.
Ahmed, Rayaz; Singh, Reema; Kapoor, Jyotsna; Chandra Patra, Pritish; Agrawal, Narendra; Bhurani, Dinesh; Halder, Rohan.
Affiliation
  • Ahmed R; Department of Hematology and Bone Marrow Transplant Unit, Rajiv Gandhi Cancer Institute and Research Centre, Delhi, India.
  • Singh R; Department of Hematology and Bone Marrow Transplant Unit, Rajiv Gandhi Cancer Institute and Research Centre, Delhi, India. Electronic address: reemasinghcr@gmail.com.
  • Kapoor J; Department of Hematology and Bone Marrow Transplant Unit, Rajiv Gandhi Cancer Institute and Research Centre, Delhi, India.
  • Chandra Patra P; Department of Hematology and Bone Marrow Transplant Unit, Rajiv Gandhi Cancer Institute and Research Centre, Delhi, India.
  • Agrawal N; Department of Hematology and Bone Marrow Transplant Unit, Rajiv Gandhi Cancer Institute and Research Centre, Delhi, India.
  • Bhurani D; Department of Hematology and Bone Marrow Transplant Unit, Rajiv Gandhi Cancer Institute and Research Centre, Delhi, India.
  • Halder R; Department of Hematology and Bone Marrow Transplant Unit, Rajiv Gandhi Cancer Institute and Research Centre, Delhi, India.
Clin Lymphoma Myeloma Leuk ; 23(2): e71-e77, 2023 02.
Article in En | MEDLINE | ID: mdl-36566108
Subject(s)
Key words
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Leukemia, Myelogenous, Chronic, BCR-ABL Positive / Leukemia, Myeloid, Chronic-Phase / Antineoplastic Agents Type of study: Diagnostic_studies Limits: Adult / Humans Country/Region as subject: Asia Language: En Journal: Clin Lymphoma Myeloma Leuk Journal subject: NEOPLASIAS Year: 2023 Document type: Article Affiliation country: India Country of publication: Estados Unidos
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Leukemia, Myelogenous, Chronic, BCR-ABL Positive / Leukemia, Myeloid, Chronic-Phase / Antineoplastic Agents Type of study: Diagnostic_studies Limits: Adult / Humans Country/Region as subject: Asia Language: En Journal: Clin Lymphoma Myeloma Leuk Journal subject: NEOPLASIAS Year: 2023 Document type: Article Affiliation country: India Country of publication: Estados Unidos